189301 | 189301 | Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS) | Completed | No Results Available | Amyotrophic Lateral Sclerosis | Drug: TCH346 | https://ClinicalTrials.gov/show/NCT00072709 |
189302 | 189302 | “SALT Trial†Study of Ascending Levels of Tolvaptan in Hyponatremia | Completed | No Results Available | Hyponatremias|Water Intoxication|Inappropriate ADH Syndrome|Water-Electrolyte Imbalances | Drug: tolvaptan | https://ClinicalTrials.gov/show/NCT00072683 |
189303 | 189303 | A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer | Completed | No Results Available | Prostate Cancer | Drug: Trabectedin | https://ClinicalTrials.gov/show/NCT00072670 |
189304 | 189304 | Cognitive-Behavioral Therapy and Tai Chi Chih for Patients With Rheumatoid Arthritis | Completed | No Results Available | Rheumatoid Arthritis | Behavioral: Cognitive Behavioral Therapy|Behavioral: Tai Chi Chih|Behavioral: Health Education Seminar | https://ClinicalTrials.gov/show/NCT00072657 |
189305 | 189305 | Pharmacokinetic Interactions With Prednisolone in Healthy Volunteers and HIV-Infected Patients Receiving Single-Dose Prednisone | Completed | No Results Available | Healthy | | https://ClinicalTrials.gov/show/NCT00072644 |
189306 | 189306 | Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung Cancer | Completed | No Results Available | Advanced Non Small Cell Lung Cancer|Failed Prior Chemotherapy | Drug: Tarceva (Trademark) (erlotinib HCl, OSI-774) | https://ClinicalTrials.gov/show/NCT00072631 |
189307 | 189307 | Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients | Completed | No Results Available | NSCLC | Drug: Exisulind | https://ClinicalTrials.gov/show/NCT00072618 |
189308 | 189308 | Experimental Ebola Vaccine Trial | Completed | No Results Available | Hemorrhagic Fever, Ebola|Healthy | Drug: VRC-EBODNA012-00-VP | https://ClinicalTrials.gov/show/NCT00072605 |
189309 | 189309 | An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies | Completed | No Results Available | Wegener's Granulomatosis | Drug: Rituximab | https://ClinicalTrials.gov/show/NCT00072592 |
189310 | 189310 | Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment | Completed | No Results Available | Leukemia | Biological: sargramostim | https://ClinicalTrials.gov/show/NCT00072579 |
189311 | 189311 | Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer | Completed | Has Results | Primary Peritoneal Carcinoma|Recurrent Ovarian Carcinoma|Stage IV Ovarian Cancer | Biological: Bevacizumab|Drug: Cyclophosphamide|Other: Laboratory Biomarker Analysis | https://ClinicalTrials.gov/show/NCT00072566 |
189312 | 189312 | Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | Active, not recruiting | No Results Available | Colorectal Cancer | Drug: celecoxib|Drug: fluorouracil|Drug: leucovorin calcium|Drug: oxaliplatin|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapy | https://ClinicalTrials.gov/show/NCT00072553 |
189313 | 189313 | S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix | Withdrawn | No Results Available | Stage 0 Cervical Cancer|High-grade Squamous Intraepithelial Lesion | Drug: celecoxib|Procedure: anti-cytokine therapy|Procedure: antiangiogenesis therapy|Procedure: biological therapy|Procedure: cancer prevention intervention|Procedure: chemoprevention of cancer|Procedure: enzyme inhibitor therapy|Procedure: growth factor antagonist therapy | https://ClinicalTrials.gov/show/NCT00072540 |
189314 | 189314 | Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | Completed | No Results Available | Lung Cancer | Drug: carboplatin|Drug: cisplatin|Drug: etoposide|Drug: irinotecan hydrochloride|Radiation: radiation therapy | https://ClinicalTrials.gov/show/NCT00072527 |
189315 | 189315 | Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies | Completed | No Results Available | Adult Nasal Type Extranodal NK/T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymph | Drug: gemcitabine hydrochloride|Drug: carboplatin|Drug: dexamethasone|Biological: rituximab | https://ClinicalTrials.gov/show/NCT00072514 |
189316 | 189316 | Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer | Completed | No Results Available | Breast Cancer | Procedure: breast imaging study|Procedure: comparison of screening methods|Procedure: magnetic resonance imaging|Procedure: radiomammography|Procedure: ultrasound imaging | https://ClinicalTrials.gov/show/NCT00072501 |
189317 | 189317 | Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma | Active, not recruiting | No Results Available | Lymphoma|Neuroblastoma|Sarcoma | Procedure: computed tomography|Procedure: magnetic resonance imaging|Procedure: positron emission tomography | https://ClinicalTrials.gov/show/NCT00072488 |
189318 | 189318 | Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes | Completed | Has Results | Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms | Drug: vatalanib | https://ClinicalTrials.gov/show/NCT00072475 |
189319 | 189319 | Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ | Active, not recruiting | No Results Available | Breast Cancer | Drug: tamoxifen citrate|Drug: Anastrozole | https://ClinicalTrials.gov/show/NCT00072462 |
189320 | 189320 | Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma | Terminated | Has Results | Lymphoma | Biological: rituximab | https://ClinicalTrials.gov/show/NCT00072449 |
189321 | 189321 | Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors | Completed | No Results Available | Unspecified Adult Solid Tumor, Protocol Specific | Drug: gemcitabine hydrochloride|Drug: alvocidib|Other: pharmacological study | https://ClinicalTrials.gov/show/NCT00072436 |
189322 | 189322 | Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer | Completed | No Results Available | Ovarian Cancer | Radiation: yttrium Y 90 monoclonal antibody Hu3S193 | https://ClinicalTrials.gov/show/NCT00072410 |
189323 | 189323 | Systemic Vincristine, Carboplatin, and Etoposide, Subtenon Carboplatin, and Local Ophthalmic Therapy in Treating Children With Intraocular Retinoblastoma | Completed | No Results Available | Intraocular Retinoblastoma | Drug: liposomal vincristine sulfate|Procedure: cryosurgery|Procedure: laser surgery|Drug: carboplatin|Drug: etoposide|Biological: filgrastim | https://ClinicalTrials.gov/show/NCT00072384 |
189324 | 189324 | Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma | Active, not recruiting | No Results Available | Neuroblastoma | Biological: anti-GD2 murine IgG3 monoclonal antibody 3F8|Biological: anti-GD2 murine IgG3 monoclonal antibody 3F8 | https://ClinicalTrials.gov/show/NCT00072358 |
189325 | 189325 | Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma | Completed | No Results Available | Intraocular Melanoma|Melanoma (Skin) | Drug: lomustine|Drug: temozolomide|Drug: thalidomide | https://ClinicalTrials.gov/show/NCT00072345 |
189326 | 189326 | Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | Completed | No Results Available | Esophageal Cancer|Gastric Cancer|Unspecified Adult Solid Tumor, Protocol Specific | Drug: cisplatin|Drug: edotecarin | https://ClinicalTrials.gov/show/NCT00072332 |
189327 | 189327 | Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer | Completed | No Results Available | Breast Cancer | Biological: filgrastim|Drug: cyclophosphamide|Drug: epirubicin hydrochloride|Drug: paclitaxel|Procedure: adjuvant therapy|Procedure: neoadjuvant therapy | https://ClinicalTrials.gov/show/NCT00072319 |
189328 | 189328 | Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases | Active, not recruiting | No Results Available | Breast Cancer | Procedure: axillary lymph node dissection|Procedure: No axillary lymph node dissection | https://ClinicalTrials.gov/show/NCT00072293 |
189329 | 189329 | Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma | Terminated | Has Results | Sarcoma | Biological: dactinomycin|Drug: cyclophosphamide|Drug: etoposide|Drug: ifosfamide|Drug: vincristine sulfate|Procedure: Conventional Surgery|Biological: MESNA (mercaptoethane sulfonate)|Biological: Filgrastim | https://ClinicalTrials.gov/show/NCT00072280 |
189330 | 189330 | UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer | Completed | No Results Available | Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer | Drug: 7-hydroxystaurosporine|Drug: topotecan hydrochloride | https://ClinicalTrials.gov/show/NCT00072267 |